Exploring the biology of gastric tumors in Latino patients
Understanding the biology of disparity-associated genomically stable gastric tumors
This study is looking at the biology of stomach tumors that are more common in Latino patients, aiming to understand why these tumors can be so aggressive, with hopes of finding better treatments to help those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11177974 on NIH RePORTER |
What this research studies
This research investigates the biology of genomically stable gastric tumors, particularly in Latino patients who are disproportionately affected by this type of cancer. The study aims to understand the molecular characteristics and epigenetic factors that contribute to the poor prognosis associated with these tumors. By analyzing tumor samples and comparing them to normal tissue, researchers will identify key biological pathways that may explain the aggressive nature of these cancers. The findings could lead to better-targeted therapies and improved outcomes for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are Latino individuals diagnosed with genomically stable gastric tumors.
Not a fit: Patients with other types of gastric cancer or those outside the Latino demographic may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better survival rates for Latino patients with gastric cancer.
How similar studies have performed: Previous research has indicated that understanding the molecular and epigenetic factors in cancer can lead to significant advancements in treatment, suggesting that this approach has potential for success.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Carvajal Carmona, Luis Guillermo — University of California at Davis
- Study coordinator: Carvajal Carmona, Luis Guillermo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.